Re: BETonMACE Enrollment
in response to
by
posted on
Aug 29, 2017 09:29AM
Thanks BDAZ, I have thought for a while that we could end up with a situation where the test group is only somewhat better than the controls but within the test group there is a large, significant difference. Obviously if Apabetalone plus Rosuvastatin proves to be very much superior to Apabetalone plus atorvastatin and also controls then this will be a home run for the company.